Lipid metabolism in the neonate. III. The ketogenic effect of Intralipid infusion in the neonate.
The ketogenic potential of Intralipid was studied in two groups of infants: 12 were SGA and 15 AGA; all were clinically stable and less than 48 hours of age. During four-hour Intralipid tolerance tests, the SGA infants achieved significantly higher plasma TG and FFA levels. Both groups of infants significantly increased the concentration of ketone bodies; however, there was no difference in the levels achieved. In view of the slower clearance rate of TG and the higher levels of FFA in SGA infants, it is speculated that in addition to a possible defective lipoprotein lipase system and a decrease in number and size of the adipose cells, beta-oxidation of FFA to ketones may be occurring at a slower rate. The generation of high levels of ketones during Intralipid infusion period in both groups of infants indicates that SGA infants can handle ketone bodies as readily as AGA infants.
D004041:Dietary Fats / Q000378:metabolism*; D004338:Drug Combinations; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005260:Female; D005990:Glycerol / Q000378:metabolism*; D006801:Humans; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D007657:Ketone Bodies / Q000096:biosynthesis*; D050356:Lipid Metabolism; D008297:Male; D010288:Parenteral Nutrition; D010713:Phosphatidylcholines / Q000378:metabolism*; D014280:Triglycerides / Q000378:metabolism
D004041:Dietary Fats; D004338:Drug Combinations; D005230:Fatty Acids, Nonesterified; D007657:Ketone Bodies; D010713:Phosphatidylcholines; D014280:Triglycerides; D005990:Glycerol